Recombinant human lysozyme (Changchun Qilong/Guoan Industrial/Shenzhen Jiuyixiang)

Product Name :
Recombinant human lysozyme (Changchun Qilong/Guoan Industrial/Shenzhen Jiuyixiang)

Search keywords :
Lysozyme

drugId :
null

Target Vo:
Peptidoglycan

Target Vo Short Name :
Peptidoglycan

Moa_Name:
Cell wall inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Changchun Qilong Institute Of Biotechnology

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Bacterial Infections

Termination Status :
Phase 1 Clinical

China Termination Status :
Phase 1 Clinical

Highest Status:
Pending

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Jagged1 Rabbit mAb Protocol
MMP7 Antibody MedChemExpress
PARP1 Antibody (YA245): PARP1 Antibody (YA245) is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to PARP1. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts